Therapy of experimental herpes simplex encephalitis with aciclovir in mice
about
Effect of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) on experimental infections in mice with herpes simplex virus type 1 strains of different degrees of virulenceEffect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in miceIn vitro susceptibility of varicella-zoster virus to acyclovirEfficacy of acyclovir against mouse cytomegalovirus in vivoTherapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virusComparative in vitro imunotoxicology of acyclovir and other antiviral agents.Herpes simplex virus ocular infections: current concepts of acute, latent and reactivated diseaseSingle-dose pharmacokinetics of acyclovir.Acyclovir treatment of experimental simian varicella infection of monkeysAcyclovir therapy of neonatal herpes simplex virus type 2 infections in rabbitsUptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected miceReplication kinetics of duck enteritis virus UL16 gene in vitro.Virus inhibition assay for measurement of acyclovir levels in human plasma and urine.Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications.Relapse of herpes simplex encephalitis after acyclovir therapy.Acute viral encephalitisTreatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.Effects of prolonged cultivation in the presence of acyclovir on recovery of latent herpes simplex virus from human trigeminal ganglia.Acyclovir therapy for the orofacial and ganglionic HSV infection in hairless mice.Potential treatment of herpes simplex virus encephalitis by brain-specific delivery of trifluorothymidine using a dihydropyridine in equilibrium pyridinium salt type redox delivery system.Strategies of drug resistance in herpes simplex.
P2860
Q28330516-9587200F-2671-420B-8230-2B3392E23CC1Q28365880-69A4EBFF-08EB-4EEB-8FEF-C05258820EEDQ28366044-A01FA063-8BFE-4FF8-9741-3F7153A18564Q28366112-5F1392B6-0B82-4824-B1EC-CD2031FF729EQ28366946-BDDC326A-F0DF-483F-8913-6FA5C7E9EC7FQ33904178-5DFE6892-AC3C-4E83-8362-D3722D855EF9Q34164499-56C4C454-952E-4DF1-A94F-EB4A9E6786BCQ35669348-452776FB-D3CB-4784-B588-6B56464807EBQ35671376-3A4B898F-13F7-495F-B444-18543B77BA1EQ35671741-0B7CB249-4968-4104-B64A-9AB75BD6B73DQ35673064-BE268B34-83A0-4815-870B-5A387C102612Q39241164-2D5735EA-F501-45B3-9A0C-294B186CD9D4Q39856159-B57FD33A-C7A7-414E-8930-E3E17E67DFCEQ40164352-928AC68D-9B52-44D0-A315-84C5003BECCFQ42252469-58A9690F-E9E4-41D9-9B20-BB34A0DCA49EQ42358239-443C15F9-A65F-4919-B825-1B0831E150F9Q42926902-B116FBA9-710E-42D7-9585-CD8127D153D3Q42928441-15AF4A13-17C0-4F26-974D-5AA6293C20B7Q43838626-6E62C7A3-FB85-4BE4-92FA-105D7AD28A50Q45836047-6B51223B-3434-44E0-87C0-4D34A886BE2FQ54549070-05294552-0D97-4F75-8638-5783CD7B6322
P2860
Therapy of experimental herpes simplex encephalitis with aciclovir in mice
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Therapy of experimental herpes simplex encephalitis with aciclovir in mice
@ast
Therapy of experimental herpes simplex encephalitis with aciclovir in mice
@en
type
label
Therapy of experimental herpes simplex encephalitis with aciclovir in mice
@ast
Therapy of experimental herpes simplex encephalitis with aciclovir in mice
@en
prefLabel
Therapy of experimental herpes simplex encephalitis with aciclovir in mice
@ast
Therapy of experimental herpes simplex encephalitis with aciclovir in mice
@en
P2093
P2860
P356
P1476
Therapy of experimental herpes simplex encephalitis with aciclovir in mice
@en
P2093
Pavan-Langston D
P2860
P304
P356
10.1128/AAC.15.6.775
P407
P577
1979-06-01T00:00:00Z